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ABSTRACT 
Liver microsomes, isolated from rats which had  been treated with phenobarbital in  vivo, 
were found to exhibit increased activities of oxidative demethylation and TPNH-cytochrome 
¢ reductase and an increased amount of CO-binding pigment. Simultaneous administration 
of  actinomycin D  or  puromycin abolished the  phenobarbital-induced enzyme synthesis. 
Increased  rate  of Pi  32  incorporation into microsomal phospholipid  was the  first  sign of 
phenobarbital stimulation and appeared 3 hours after a single injection of this drug. Micro- 
somes  were  divided into smooth-surfaced and rough-surfaced vesicle  fractions. The frac- 
tion consisting of smooth-surfaced vesicles exhibited the greatest increase in protein content 
and  oxidative  demethylation activity  after  phenobarbital  administration in  vivo.  Ultra- 
structural studies revealed that drug treatment also gave rise to proliferation of the endo- 
plasmic reticulum in the hepatic parenchymal cells,  first  noticed after two  phenobarbital 
injections. The phenobarbitaMnduced synthesis of the metabolizing enzymes is discussed 
with special reference to  the  relationship to  the  stimulated synthesis  of the  endoplasmic 
membranes. 
INTRODUCTION 
The  liver  microsomal  fraction,  isolated  after 
homogenization  and  differential  centrifugation, 
contains  free  RNP  particles  and  two  kinds  of 
vesicles:  rough,  with RNP  1 particles  attached  to 
1Abbreviations used  are-  RNP,  ribonucleoprotein; 
DPNH  and  TPNH,  di-  and  triphosphopyridine 
nucleotide,  reduced  forms;  i.p.,  intraperitoneally; 
RNA, ribonucleic acid; DNA, deoxyribonucleic acid; 
ER,  endoplasmic  reticulum;  DOC,  deoxycholate, 
IDP,  inosine-51-diphosphate;  ATP,  adenosine-51- 
the  outer surface,  and smooth,  which  lack  these 
particles  (1).  Liver  microsomes  are  known  to 
catalyze a number of TPNH-dependent hydroxyla- 
tion reactions, among them the oxidative demethy- 
lation of various  drugs  (cf.  review,  2).  TPNH- 
cytochrome c reductase (3-5) and the CO-binding 
pigment (6,  7)  are probably involved in oxidative 
demethylation  (8-10).  Pretreatment  of  rats  in 
triphosphate; G-6-P,  glucose-6-phosphate; FA, form- 
aldehyde. 
627 vivo  with  certain  drugs,  e.g.  phenobarbital,  in- 
duces  an  increased  rate  of  drug  hydroxylation 
(11-13)  and  also  leads  to  increased numbers  of 
endoplasmic membranes (14).  It is the purpose of 
this  paper  to  present  data  which  indicate  that 
phenobarbital acts by the specific induction of the 
synthesis  of TPNH-cytochrome  c  reductase  and 
the  CO-binding pigment, and  that this substrate 
induction is sensitive to actinomycin D  and puro- 
mycin.  The  phenobarbital-induced enzyme  syn- 
thesis will  be  discussed with  special  reference to 
the  production  of  the  enzyme-bearing  endo- 
plasmic  membranes,  as  studied  by  chemical 
methods and in the electron microscope. 
MATERIALS  AND  METHODS 
Male  Spraguc-Dawley rats  (200  to  300  gin)  were 
used. All animals were starved overnight and killed 
by decapitation. The livers were excised and placed 
at  once in cold 0.25 M sucrose. They were weighed, 
cut into small pieces, and washed clean of blood by 
rinsing with cold sucrose. 
Microsomes  were  prepared  according  to  the 
method described by Ernster et al.  (15). 
The experimental animals were given one daily in- 
jection  of  100  mg  of phenobarbital  per  kg  body- 
weight intraperitoneally (i.p.). The controls received 
the same amount of 0.9 per cent NaCl. Actinomycin 
D  was also administered i.p.  in an amount of 8  pg 
per 100 gm of body-weight. 
For the electron microscopic investigations, small 
pieces  of the  liver  from cxperimental  animals  and 
controls were fixed for  1.5  to 2 hours at 0-4°C in 2 
per  cent  osmium  tctroxidc,  buffered  with  purified 
s-collidine (16)  or a  phosphate buffer (pH 7.4)  (17). 
After dehydration in a  graded series of ethanol solu- 
tions, starting with 70 per cent, the tissues  were im- 
mersed in two changes of propylene oxide and were 
then embedded in Epon 812  (18).  Thin sections were 
stained with lead hydroxide (19)  and examined in a 
Siemens Elmiskop I  electron microscope. 
Protein was  measured  by  the  method  of Lowry 
et al. (20).  RNA was determined according to Ceriotti 
(21).  Lipids were extracted (22)  and the phosphorus 
content  estimated  (23).  The  value  obtained  was 
multiplied  by  25  to  obtain  the  total  amount  of 
phospholipid (15). 
Oxidative  demethylation  activity  was  assayed 
with  aminopyrine as  substrate.  The  incubation sys- 
tem  contained  mierosomes,  5  mM  aminopyrine, 
0.05 M  tris buffer (pH 7.5), 50 m~ nicotinamide, 5 mM 
MgC12, 0.5 mu TPN, and a TPNH-generating system 
consisting of 5 mM nL-isocitrate, 0.01  mu MnC12, and 
enough isocitric dehydrogenase to reduce 0.32/~moles 
TPN per minute, in a final volume of 2 ml. The time 
of incubation was 20  minutes and  the  temperature 
37°C.  The  amount  of  formaldehyde  formed  was 
measured by the Nash reaction (24). 
Oxygen consumption was measured with a  Clark 
oxygen electrode.  Measurements were  started  with 
microsomes and 0.3  mM TPNH, in a  final volume of 
3  mi.  After  recording  the  TPNH  oxidase  activity, 
the drug was added to a final concentration of 5 raM. 
The temperature was 30°C. 
All other enzyme assays were performed according 
to previously described methods (15,  25). 
Abbreviations 
BC, bile capillary. 
C, cytosome. 
CM, cell membrane. 
CS, cytosegresome 
erg, rough-surfaced ER. 
ers, smooth-surfaced ER. 
Gl, glycogen. 
M, mitochondrion. 
Mb, microbody. 
N, nucleus. 
S, sinusoid. 
The electron micrographs in plates 1 to 6 are from thin sections of Epon-embedded tissues; 
the sections were stained with lead hydroxide prior to examination in the microscope and 
show the appearance of hepatic parenchymal  cells. 
FmURE  1  Control  (intraperitoneal injections of physiologic saline  for 5  days).  Long, 
slender profiles of rough-surfaced ER (erg) tend to be arranged in parallel arrays. Smooth- 
surfaced ER appears as short tubular or vesicular images. Transitions between rough- and 
smooth-surfaced ER  (unattached arrow)  are relatively frequent.  )<  15,000. 
FIGURE  ~  Intraperitoneal injections of phenobarbital for  3  days.  As  compared  with 
the control, considerably increased numbers of tubular and vesicular images,  believed to 
represent proliferated smooth-surfaced ER (ers), are present in the cytoplasm. ×  ~3,000. 
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from Dr. J. R. Tata, Mill Hill, London. Actinomycin 
D  was  made  available  to  us  by  Merck,  Sharp  & 
Dohme,  International.  All chemicals employed were 
standard  commercial products. 
A  part  of  this  work  has  already  been  reported 
briefly (26). 
RESULTS 
A.  Electron .~licroscopy  2 
The  cytoplasm  of  hepatic  parenchymal  cells 
from  control  animals  given  physiologic  saline 
i.p.  (Fig.  l) showed  an appearance similar to that 
in normal rat and mouse.  In experimental animals 
given  phenobarbital  alone,  alterations  of  the 
endoplasmic  reticulum  (ER)  were  noted  in  some 
of the animals sacrificed 2 days after the beginning 
of the injections,  and  in  all of those sacrificed on 
the  3rd  day  and  later.  The  earliest changes  (ob- 
served  in  animals  sacrificed  on  the  2nd  and  3rd 
day)  consisted in proliferation of the ER  (Fig.  2). 
Smooth-surfaced  tubular  and  vesicular  profiles 
of ER were  more  abundant  than  in  control  ani- 
mals,  but otherwise showed  the same  appearance 
as  in  the  latter.  Unequivocal  alterations  in  the 
structure  or disposition  of the rough-surfaced  ER 
were  not  observed.  Moderate  numbers  of "free" 
RNP  particles  were  present  in  the  cytoplasmic 
ground  substance.  On the 4th and  5th days  (Figs. 
3  to  5),  the  cytoplasmic  ground  substance  was 
filled  with  tightly  packed  smooth-  and  rough- 
surfaced  profiles  of the  ER.  Rough-surfaced  ER 
appeared  to  be  more  abundant  than  in  control 
2 A  brief account of the observations is given below. 
The  ultrastructural  alterations  will  be  described 
more comprehensively elsewhere. 
animals,  and large areas of cytoplasm occupied by 
conglomerations  of  rough-surfaced  tubular  pro- 
files  arranged  in  parallel  arrays  were  often  en- 
countered  (Fig.  4).  Smooth-surfaced  ER  usually 
appeared as circular or oval vesicles. Both smooth- 
and  rough-surfaced  ER  often  showed  dilatation 
to  a  variable  degree.  Significant  alterations  in 
cytoplasmic organelles other than those of the ER 
were not observed. 
A  moderate proliferation of the ER occurred in 
hepatic parenchymal cells of experimental animals 
which  had  received  both  phenobarbital  and 
actinomycin  D  (Fig.  6).  This  alteration  was  first 
observed on the  3rd  day.  Dilatation  and  extreme 
proliferation of the ER,  as noted in animals given 
phenobarbital  alone, was not present.  Administra- 
tion  of  actinomycin  D  alone  did  not  cause  any 
appreciable  alterations  in  liver cell  structure. 
B.  Biochemistry 
Phenobarbital  treatment  resulted  in  increased 
amounts  of microsomal protein,  RNA,  and  phos- 
pholipid  (Fig.  7).  The  phospholipid  content  was 
already significantly higher after one phenobarbi- 
tal injection and exhibited  a  greater  increase  than 
RNA and protein. 
Fig. 8  shows the response of several microsomal 
enzymes  to  phenobarbital  treatment.  After  five 
injections,  there  was  a  4-  to  5-fold  increase  over 
controls  in  the  aminopyrine-demethylating  and 
TPNH-cytochrome  c  reductase  activities  and  in 
the amount  of CO-binding  pigment,  all  as calcu- 
lated  on  the  protein  basis.  The  specific  IDPase 
activity, measured  in  the presence of 0.1  per cent 
DOC,  and the content of cytochrome bs,  as calcu- 
lated  per mg  protein,  were  about  the same  as  in 
the controls, while the specific activities of glucose- 
FIGURE 3  Four  intraperitoneal  injections  of  phenobarbital.  The  cytoplasmic  ground 
substance  contains numerous  vesicles,  most  of  which  are  smooth-surfaced.  The  rough- 
surfaced ER (erg) shows dilatation.  X  15,000. 
FIGURE 4  Four intraperitoneal injections of phenobarbital. Area of cytoplasm containing 
numerous  cisternae  of rough-surfaced  ER  (erg) arranged  in  a  parallel fashion.  Most  of 
the cisternae are expanded at their ends where some become smooth-surfaced (mlattached 
arrow). The cytoplasm surrounding the stacked cisternae is mainly composed of smooth- 
surfaced  vesicular profiles.  In the right  upper corner is an area  (indicated  by CS)  con- 
taining ER which seems to have been segregated from the remainder of the cytoplasm by 
a system of roughly parallel membranes. Such images have been termed "cytosegresomes" 
and probably contain acid phosphatase  (46). X  20,000. 
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c  reductase  were  lower  in  the  treated  animals 
than in the controls. 
Twelve  hours  after  one  single  dose  of  pheno- 
barbital,  there  was  a  significant  increase  in  the 
rate  of oxidative  demethylation  and  the  concen- 
tration of the participating  enzymes  (Fig.  9).  The 
rate of P132 incorporation into microsomal phospho- 
lipid,  however,  exhibited  more  than  a  2-fold 
increase  already  3  hours  after  the  administration 
of phenobarbital,  and  reached  its  maximum  12 
hours  after the injection. 
In untreated rats,  as well as in mice and guinea 
pigs,  the  TPNH-cytoehrome  c  reductase  and 
oxidative demethylation  activities and the amount 
of  CO-binding  pigment  have  been  found  to  be 
equally  distributed  within  microsomal  subfrac- 
tions;  i.e.  rough-  and  smooth-surfaced  vesicles 
(27).  Fig.  10  shows  that  following  stimulation 
with  phenobarbital  there  was  a  greater  increase 
in the amount of protein and oxidative demethyla- 
tion  activity  in  the  fraction  containing  smooth 
vesicles  as  compared  to  the  one  predominantly 
composed  of rough  vesicles;  the  latter,  however, 
also  exhibited  a  highly  significant  response  to 
phenobarbital  stimulation  which  is  in  agreement 
with previous findings  (28). 
Fig.  11  shows  the  effect  of actinomycin  D  on 
drug-induced  enzyme  synthesis.  This  antibiotic 
exerted a  strong inhibitory effect at the beginning 
of  the  treatment;  however,  following  repeated 
injections of phenobarbital,  it was  no  longer pos- 
sible to prevent an increase in enzymatic activities 
with  simultaneous  administration  of actinomycin 
D.  Puromycin  completely  abolished  the  pheno- 
barbital-stimulated increase in the concentration of 
CO-binding pigment and oxidative demethylation 
activity (Table I). 
There was  a  3- to 4-fold increase  in  the rate  of 
Pi  32  incorporation  into  microsomal  phospholipid 
12  hours  after  a  single  phenobarbital  injection 
(Fig.  12).  No significant increase over the controls 
was found in this incorporation rate when  actino- 
mycin D  was  given alone.  Simultaneous  adminis- 
tration of phenobarbital  and this antibiotic caused 
an  increased rate of Pi :~2 incorporation into micro- 
somal lipid phosphorus;  although  this stimulation 
of  the  incorporation  rate  was  found  to  be  sig- 
nificantly  lower  than  the  stimulation  caused  by 
giving  phenobarbital  alone.  Treatment  with 
phenobarbital  also  increased  the  rate  of  Pi 32  in- 
corporation into mitochondrial phospholipid,  to  a 
much  lesser  extent,  however.  It  cannot  be  ex- 
cluded  that  the  stimulation,  at  least  in  part,  de- 
pended  on  contamination  of  the  mitochondrial 
fraction with microsomes. 
Table  II  shows  the  stimulation  of the  TPNH- 
dependent  oxygen  uptake  caused  by  addition  of 
various drugs  to microsomes isolated from pheno- 
barbital-treated  and  control  animals.  For  all  the 
drugs  added,  the increase in oxygen consumption 
was  found  to  be  stimulated  several  times  by  re- 
peated  phenobarbital  administration  in  vivo.  It 
may be noted  that  the microsomal TPNH-oxidiz- 
ing activity, measured  in the absence of substrate, 
was  not  significantly  increased  by  phenobarbital 
treatment.  The  molar  amount  of  formaldehyde 
formed  from  the  oxidatively demethylated  drugs 
was the same as the amount of oxygen consumed. 
There  are  many  similarities  between  the  re- 
sponse  of  rat  liver  to  phenobarbital  stimulation 
and  the  effects of administration  of thyroid  hor- 
mone  to  a  thyroidectomized  rat  (cf.  review,  29); 
e.g.,  increased  liver  weight,  increased  protein 
synthesis,  increased  TPNH-cytochrome  c  re- 
ductase  activity, sensitivity to actinomycin D,  and 
the  relatively  long  time  lag  before  measurable 
changes occur.  In order to study the possible role 
of the  thyroid  hormone  in  drug-induced  enzyme 
synthesis,  thyroidectomized rats  that had received 
FIGURE 5  Five  intraperitoneal  injections  of  phenobarbital.  The  cytoplasm  contains 
numerous dilated cisternae of rough-surfaced  ER  (erg),  often showing irregular outlines. 
There  are  also  abundant  profiles  of  smooth-surfaced  vesicular,  oval,  or  short  tubular 
images,  probably  representing dilated  (possibly  also  fragmented),  smooth-surfaced  ER. 
In the right lower corner is a "eytosegresome" similar to that shown in Fig. 4.  X  16,000. 
FmVRE  6  Five intraperitoneal injections of phenobarbital and actinomyein D. Abundant 
smooth-  (ers)  and  rough-surfaced  (erg)  ER  in  the  cytoplasm.  (Compare  with  Fig.  1). 
X  1~,500. 
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I~GURE 7  Effect of phenobarbital treatment on micro- 
somal protein,  RNA,  and  phospholipid.  Mean  values 
(in mg per gm liver) of six phenobarbital-treated rats 
are plotted, expressed as percentage of the mean values 
obtained from a control gloup of six rats. Phenobarbital 
injections  are  marked  with  arrows.  The  averages  4- 
standard  deviations  for  the  phenobarbital-treated 
groups  (Exp.)  and the control groups  (Con.)  were the 
following: 
No, of 
pheno- 
barbital 
treatmenls 
Con. 
1  Exp. 
Con. 
2  Exp. 
Coil. 
3  Exp. 
Con. 
4  Exp. 
Con. 
5  Exp. 
Protein 
mg/gm  liver 
'24.1  -4-  1.46 
23.9  4-  1.54 
23.1  4-  1.34 
27.7  4-  1.28 
i24.1  -4-  1.30 
31.4  4-  1.52 
RNA 
mg/gm  liver 
4.82  4-  0.38 
4.62  4-  0.32 
4.50  4-  0.34 
5.31  -4-  0.41 
4.28  4-  0.29 
5.56  -4-  0.40 
Phospholipid 
mg/gm  liver 
6.75  4-  1.27 
10.00  4-  1.27 
6.40  -4-  1.20 
10.77  4-  2.00 
6.22  4-  1.18 
11.70  4-  2.10 
0  37 [ 6  05  4-  1.18  22.8  4-  1.384.30  -4-  i 
33.1  4-  2.226.84  4-  0171,12170  4-  2.72 
22.0  4-  1.50,4.40  -4-  0.46  6.30  4-  1.40 
35.8  4-  3.0017.08  4-  0.90i15.10  -4-  3.20 
no,  one,  or  three  injections  of  triiodothyronine, 
were subjected to phenobarbital treatment (Table 
III).  ~[he  increase  in  the  specific  aminopyrine- 
demethylating and TPNH-cytochrome c reductase 
activities  and  in  the  amount  of CO-binding  pig- 
ment, as calculated per mg protein, was about the 
same  as  in  the  non-thyroidectomized  controls. 
This  finding indicates  that  thyroid  hormones  are 
not  involved  in  phenobarbital-induced  enzyme 
synthesis. 
DISCUSSION 
It is well documented  that treatment of rats with 
certain  drugs  induces  an  increased  tolerance  to 
the  action  not  only  of the  specific  drug  used  for 
pretreatment  but  also  of  a  whole  group  of com- 
pounds which share the property of being hydroxy- 
lated by liver microsomal enzymes in the presence 
of  TPNH  and  oxygen  (ll-13,  30).  It  has  been 
postulated  that  the  inducing  agents  act  by caus- 
ing  an  increased  synthesis  of  the  microsomal 
drug-metabolizing enzymes (13, 28, 31).  Adminis- 
tration of ethionine was shown to inhibit the drug- 
induced increase in the activities of the metaboliz- 
ing  enzymes  (13,  31),  and  Gelboin  and  Sokoloff 
reported that treatment with phenobarbital, which 
is one of the most  potent  inducing agents,  stimu- 
lated the incorporation of amino acids into micro- 
somal  proteins of cell-free liver preparations  (32). 
It  was  recently  shown  that  phenobarbital stimu- 
lation of the activities of several drug-metabolizing 
enzymes  is  associated  with  increased  numbers  of 
endoplasmic membranes (14,  28). 
Earlier  results  suggested  that  TPNH-cyto- 
chrome c reductase  and the  CO-binding pigment 
are involved in liver-microsomal drug-hydroxylat- 
ing  reactions  (8-10).  Strong  evidence  for  the 
involvement  of  these  two  enzymes  in  oxidative 
demethylation was obtained in the present study. 
Repeated  administration of phenobarbital to  rats 
caused  a  ca.  1.5-fold  increase  in  the  amount  of 
microsomal  membrane  constituents--protein, 
RNA,  and  phospholipid--while  the  activities  of 
aminopyrine  demethylation  and  TPNH-cyto- 
chrome c reductase and the amount of CO-binding 
pigment,  all  as  calculated  on  the  protein  basis, 
exhibited a  4- to 5-fold increase over the controls. 
The  amount of cytochrome  bs, calculated  per mg 
protein, did not change, while DPNH-cytochrome 
c reductase showed a  lower specific activity in the 
drug-treated  animals; this was  also  true for ATP- 
ase  and  glucose-6-phosphatase.  The  fact  that 
treatment with phenobarbital causes a  several-fold 
increase  in  the  concentration  of only  one  of  the 
microsomal  hemoproteins,  the  CO-binding  pig- 
ment, and in the activity of only one of the micro- 
somal  flavoproteins  TPNH-cytochrome  c  re- 
ductase,  indicates  that  the  induction  is  a  specific 
substrate-caused  de  novo  synthesis  of  the  metabo- 
lizing enzymes. 
However,  stimulation  with  phenobarbital  also 
leads  to  proliferation  of  the  ER.  It  would  thus 
appear  that  the  newly  synthesized  enzymes  are 
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FIGURE  8  Effect of phenobarbital treatment on certain mierosomal enzymes. The mean values of the 
specific  activities of the enzymes of the phenobarbital-treated group (six rats) are plotted in relation to 
the same values of the control group (six rats). Arrows indicate phenobarbital injections. The averages 
standard deviations for the phenobarbital-treated groups (Exp.) and the control groups (Con.) were the 
following: 
No, of pheno- 
barbital 
ueatments 
1  Con. 
Exp. 
Con. 
2  Exp. 
Con. 
3  Exp. 
Con. 
4  Exp. 
Con. 
5  Exp. 
Demethyla-  TPNH-cyto-  ]  I DPNH-ey-  CO-binding  [  Cytochrome  A  tion  "  chrome ¢  IDPase  G-6-Pase  toehrome  TPase 
.........  p*gment  reduetase  b5  c reductase 
m#moles  ^  E  lamoles  TPNH  I  #moles  Pi/  A E  Izmoles  Pi/  ]  Izmoles  #moles  Pi/ 
46o ~0o/  ~a  42~  41o/  FA/min./  -  ox./rain./  I  20  rain.~  -  20  min./  I DPNH  ox./  20  min./ 
mg prot.  i  mg prot.  . 
rag  prot.  mg prot.  I  mg prot.  rag  prot.  I ra*n,/mg  prot  mg prot. 
2.80  4.  0.370.019  4.  0.0070.020  -4-  0.004L7.20 -4-  0.52 D  103  -4-  00303.12  4-  0.3510.62 4-  0.1', 1.95 4.  0.24 
5.56  -4-  0.900036  4.  00090042  4-  0006!718  4-  070, D089  4-  00241240  4-  026032  4-  006101  4-  013 
3.05  4.  0.400.022  4.  0.007}0.019 4.  0,003 7.00 ::t: 0.401D.090 4.  0.0293.40  4.  0.41 0.71  4.  0.142.20  4-  0.26 
6.70  4.  1.120.067  4.  0.010;0.045 4.  0.0076.98  4.  0.56 3.085 4.  0.0202.16  4-  0.200.25  4-  0.04 1.36 4.  0.14 
9.51  4-  1.20 
3.10  4-  0.45  .  2  ::k:  •  •  2  4-  •  7.  4-  •  2  ....  01  i  '  4-  •  .  ::h  .  2,  2  4.  0.30 
13.50  4.  1.400.075  4.  0.0100.087  4-  0.0087.40  4-  0490.082  -4-  0.0242.08  4.  0.290.26  4.  0.04'0.84  4-  0.13 
311  4.  0,600.022  4.  0.00610.026  4-  0,00517.19  4-  0.3010.100  4-  0.03013.12  4-  0341062  4-  009195  4-  024 
15.80  4-  1.52 0.100  4.  0.01410.113  4-  0.017  7.45  ::b  0.53 0.088  4-  0.026  1.54  4-  0.16i0.27  4-  0.05i0.82  4-  0.11 
dependent upon the production of new membranes 
in order to function. This view is further supported 
by  the  increased  rate  of  Pi 3~  incorporation  into 
microsomal  phospholipids,  which  was  the  first 
sign of phenobarbital stimulation. 
The  fastest  and  greatest  increase  in  the  sub- 
strate-induced  enzyme  levels  was  found  in  the 
fraction  containing  smooth-surfaced vesicles.  This 
is  in  agreement with  the  results  of Remmer  and 
Merker (28). An increased amount of endoplasmic 
membranes was found  by electron  microscopy in 
hepatic  parenchymal  cells  after  two  to  three  in- 
jections  of  phenobarbital.  The  earliest  alteration 
was  the  appearance  of  small  smooth-surfaced 
vesicular  and  tubular  profiles  in  the  cytoplasm. 
Following  further  injections,  an  increase  in  the 
amount  of  rough-surfaced  membranes  was  also 
observed.  It  is  possible  that  drug  treatment  first 
gives  rise  to  a  synthesis  of  smooth  membranes; 
some of these may later become coated with RNP 
particles. 
Microsomes  catalyze  a  TPNH-dependent  02 
ORRENIUS,  ERICSSON, AND  ERNSTF.R  Phenobarbital-Induced  Synthesis  635 300 
-5 
o 
o  20(; 
100' 
o 
,"  "... 
,"  "-% 
,o 
o*  ,,  ,,  °, 
I["  %-. 
~,'"  "%, 
/  /  -  ....  ..~ 
:  k, 
1'2  1'8  2'4 
Hours 
FIGURE  9  Increased  rate  of  Pi  ~  incorporation  into 
microsomal  phospholipid,  and  increase  in  oxidative 
demethylation  and  TPNH-cytochrome  e  reductase 
activities and  in  the  amount  of  CO-binding pigment 
after one phenobarbital  injection. Pi  ~  incorporation is 
plotted as ePM per mg lipid phosphorus  of the treated 
rats as percentage of controls.  1 mc  Pi  ~  was  given i.p. 
to  each  rat  1  hour  before it  was  killed.  -----O,  Pi ~ 
incorporation.  --X,  Demethylation.  -.--©.,  CO- 
binding  pigment.  -  -  -A,  TPNH-cytochrome  c  re- 
ductase. 
uptake,  which  is  known  as  the  TPNH  oxidase 
(33).  This O2 uptake  is not inhibited by CO,  as is 
drug  hydroxylation  (34).  Addition  of a  hydroxyl 
acceptor  increases  the  microsomal  TPNH-de- 
pendent  Oo uptake,  and  this increase is CO sensi- 
tive. The increase in oxygen consumption,  caused 
by the addition of various drugs,  was found  to be 
stimulated  several-fold by repeated  phenobarbital 
administration  in vivo. 
Actinomycin  D,  which  is  known  to  block  the 
DNA-dependent  synthesis  of  messenger-RNA 
(35-37),  initially  abolished  the  phenobarbital- 
induced  enzyme synthesis.  This result is in  agree- 
ment with the findings of Gelboin  and  Blackburn 
for the stimulatory effect of 3-methylcholanthrene 
on  microsomal  amino  acid  incorporation  and 
benzpyrene hydroxylase activity (38)  and  those of 
Salas  et  al.  for  glucose-induced  synthesis  of liver 
glucokinase  (39).  The  effects  of  many  doses  of 
phenobarbital  could  not  be  totally  abolished  by 
simultaneous  administration  of  actinomycin  D, 
which may suggest  that  the  ability of the liver to 
detoxicate this  antibiotic is increased  by repeated 
administration.  Puromycin  inhibition  occurs  at 
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FmURE  10  Effect  of  phenobarbital  treatment  on 
protein  content  and  oxidative demethylation  activity 
of  mierosomal  subfractions.  Smooth-  and  rough-sur- 
faced  vesicles  were  separated  according  to  Dallner 
(~5). Arrows indicate phenobarbital injections. --X, 
Demethylation, smooth vesicles. ----X, Demethylation, 
rough  vesicles.  ©,  Protein,  smooth  vesicles. 
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FmvnE  11  Inhibition  of  the  phenobarbital-induced 
enzyme  synthesis  by  simultaneous  administration  of 
actinomycin  D.  Solid  arrows  mark  injections  with 
phenobarbital;  dashed  arrows  mark  injections  with 
phenobarbital  and actinomycin D.----O,  CO-binding 
pigment.  --X,  demethylation.  --A,  TPNH- 
cytochrome  c  reductase.  ----0,  CO-binding  pigment. 
---)<,  demethylation.  ---~,  TPNH-cytochrome  c  re- 
ductase. 
the  stage  of  assembly  of  new  protein  at  the 
ribosome  (40).  In  the  dose  given,  puromycin 
totally  abolished  the  drug-induced  enzyme  syn- 
thesis,  which  is  in  agreement  with  the  results  of 
Conney  and  Gilman  (41)  and  a  further  evidence 
for an  actual synthesis of new enzyme protein. 
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synthesis,  measured  as increased  rate  of  Pi  ~2  in- 
corporation  into  microsomal  phospholipids,  was 
initially  and  partly  inhibited  by  simultaneous 
injection of actinomycin D.  In this case,  however, 
the inhibitory action of the antibiotic has been too 
weak to  allow  any final conclusions to be drawn. 
In  this  connection,  it  should  be  mentioned  that 
TABLE  I 
Inhibition,  by Puromycin,  of the  Phenobarbital-Induced 
Increase in  Oxidative  Demethylation  Activity and 
Amount of CO-Binding Pigment 
Oxidative 
demethylation  CO-binding 
Treatment  Protein  activity  pigment 
mg/gm liver  ml~moles  AE450_  500  / 
FA/min./mg  mg protein 
protein 
None  26.4  2.62  0.013 
Phenobarbital*  27.8  10,70  0.050 
Phenobarbital  30.0  2,76  0.013 
+Puro- 
mycin :~ 
* Three  injections  of  phenobarbital  were  given, 
once every 24 hours. 
Simultaneously with each one of the three pheno- 
barbital injections,  12.5  mg of puromycin per  100 
gm of body-weight were injected i.p. 
Mueller has reported that actinomycin D  inhibits 
the  estrogen-stimulated  phospholipid  synthesis in 
perfused rat uterus  (42). 
A large number of inducible enzyme systems has 
been discovered and studied in bacteria.  Enzymes 
that  attack  exogenous  substrates  have  generally 
been  found  inducible  in  these  organisms.  Very 
often the presence of a  substrate induces the syn- 
thesis not  of a  single,  but  of several  enzymes  se- 
quentially  involved  in  its  metabolism  (43).  At 
present,  it  is  difficult  to  perform  a  direct  com- 
parison  of  the  findings  reported  above  with  the 
results  of Monod  and  co-workers  from  the  study 
of the  "lactose"  system of E.  coli (cf.  review,  44). 
There  are,  however,  important  similarities  be- 
tween these two  systems.  The  substrates induce  a 
de  novo synthesis of enzyme  protein.  Actinomycin 
D  inhibits this synthesis.  Removal of the  inducer 
results in cessation of enzyme synthesis. However, 
further  studies  of  the  kinetics  of  phenobarbital 
induction  have  to  be  performed  before  any  con- 
clusions concerning  a  possible  analogy  with  bac- 
terial systems can be drawn. 
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Effect of Phenobarbital  Treatment  on  the Microsomal  TPNH-Dependent  Oxygen  Uptake,  as 
Stimulated by  Various Drugs 
Exp. No. 
No. of phenobarbital treatments  0  1  3 
Additions  Oxygen consumption 
mt~moles 02 consumed/rain/rag protein 
TPNH  2.60  6.00  4.85 
TPNH  +  aminopyrine  5.35  12.50  16.60 
TPNH  3.40  4.20  4.00 
TPNH  +  dimethylnitrosamine  6.15  11.10  14.00 
TPNH  3.90  3.00  7.42 
TPNH  +  codeine  5.84  9.70  16.50 
TPNH  3.72  3.00  3.12 
TPNH  +  phenobarbital  5.00  6.00  9.40 
TABLE  III 
Effect of Phenobarbital  Treatment  on  the  Oxidative  Demethylation  System  of  Thyroidectomized  Rats 
and  Thyroidectomized  +  Triiodothyronine  (T3) - Treated Rats 
No. of 
phenobarb, 
treatm. 
TPNH- 
Oxidative  cytochrome c 
demethylation  redactase  CO-binding 
Treatment  Protein  activity  activity  pigment 
mg/gm liver 
Non-thyroidectomized  25.2 
Thyroidectomized  16.6 
Thyroideetomized  +  I  T3  inj.*  19.0 
Thyroideetomized  +  3  T3  inj.:~  20.2 
ml~moles FA/  t~moles  TPNH  AE4~o_b~/mg 
min./mg protein  ox./min./mg  protein  protein 
2.95  0.029  0.020 
3.30  0.018  0.019 
3.45  0.036  0.014 
4.70  0.036  0.021 
Non-thyroidectomized  27.1  9.10  0.045  0.074 
Thyroidectomized  26.4  14.90  0.046  0.083 
Thyroidectomized  +  1 T3  inj.*  25.0  17.80  0.052  0.093 
Thyroidectomized  +  3  Ta  inj. :~  23.8  11.50  0.049  0.101 
* 45 /zg of triiodothyronine was injected subcutaneously on the 3rd day before beginning of phenobarbital 
stimulation. 
:~ 45 #g of triiodothyronine was injected subcutaneously on the 3rd, 6th,  and 8th day before beginning of 
the phenobarbital  stimulation. 
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